Mechanisms of secretion of ATP from cortical astrocytes triggered by uridine triphosphate, Neuroreport, vol.14, pp.2177-2181, 2003. ,
Synaptic Functions of Hemichannels and Pannexons: A Double-Edged Sword, Front Mol Neurosci, vol.11, p.435, 2018. ,
Synaptic vesicle proteins: targets and routes for botulinum neurotoxins, Curr Top Microbiol Immunol, vol.364, pp.159-77, 2013. ,
The tetanus toxin light chain inhibits exocytosis, FEBS Lett, vol.242, pp.245-248, 1989. ,
Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses, Toxicon, vol.56, pp.1315-1326, 2010. ,
Long-distance retrograde effects of botulinum neurotoxin A, J Neurosci, vol.28, pp.3689-3696, 2008. ,
Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A, NeuroToxicology, vol.26, pp.785-793, 2005. ,
beta-NAD is a novel nucleotide released on stimulation of nerve terminals in human urinary bladder detrusor muscle, Am J Physiol Renal Physiol, vol.290, pp.486-495, 2006. ,
2.3 A crystal structure of tetanus neurotoxin light chain, Biochemistry, vol.44, pp.7450-7457, 2005. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00009274
Identification of a novel botulinum neurotoxin gene cluster in Enterococcus, FEBS Lett, vol.592, pp.310-317, 2018. ,
Identification of a transmembrane glycoprotein specific for secretory vesicles of neuronal and endocrine cells, J. Cell Biol, vol.100, pp.1284-1294, 1985. ,
Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function, J Neurosci, vol.22, pp.6876-6884, 2002. ,
The action of botulinum toxin on the neuromuscular junction, J Physiol, vol.109, pp.10-24, 1949. ,
Direct central nervous system effects of botulinum neurotoxin, Toxicon, vol.147, pp.68-72, 1031. ,
Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats, Nat Clin Pract Urol, vol.188, pp.319-328, 1036. ,
Neurophysiology of stress urinary incontinence, Rev Urol, vol.6, pp.19-28, 2004. ,
How does synaptotagmin trigger neurotransmitter release?, Annu Rev Biochem, vol.77, pp.615-656, 2008. ,
Differential permeability of blood microvasculatures in various sympathetic ganglia of rodents, Anat Embryol (Berl), vol.194, pp.259-269, 1996. ,
Neuronal involvement in muscular atrophy, Front Cell Neurosci, vol.8, p.405, 2014. ,
Effect of onabotulinumtoxinA on intramural parasympathetic ganglia: an experimental study in the guinea pig bladder, J Urol, vol.187, pp.1121-1126, 1121. ,
Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action, Eur Urol, vol.61, pp.1178-1184, 1171. ,
Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder, Eur Urol, vol.57, pp.884-890, 1030. ,
Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats, Exp Neurol, vol.285, pp.159-166, 1025. ,
Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis, Eur J Pain, vol.23, p.513, 2014. ,
Botulinum Neurotoxin Type A is Internalized and Translocated from Small Synaptic Vesicles at the Neuromuscular Junction, Mol Neurobiol, vol.48, pp.120-127, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00850323
Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall, Cell Microbiol, vol.18, pp.282-301, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01780625
Botulinum Neurotoxin Type B Uses a Distinct Entry Pathway Mediated By Cdc42 Into Intestinal Cells Versus Neuronal Cells, Cell Microbiol, vol.19, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01493360
A neurotoxin that specifically targets Anopheles mosquitoes, Nat Commun, vol.10, p.2869, 2019. ,
Preferential entry of botulinum neurotoxin A Hc domain trhough intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine, PLoS Pathog, vol.8, 2012. ,
Differential entry of botulinum neurotoxin A into neuronal and intestinal cells, Cell Microbiol, vol.11, pp.289-308, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01758348
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain, Pain, vol.107, pp.125-133, 2004. ,
Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system, Brain Res, vol.1367, pp.130-175, 1022. ,
Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor, Sci Rep, vol.7, p.1032, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01513204
Botulism. Studies on the Manner in Which the Toxin of Clostridium Botulinum Acts Upon the Body : Ii. The Effect Upon the Voluntary Nervous System, J Exp Med, vol.38, pp.327-346, 1923. ,
Botulinum toxin: A review of the mode of action in migraine, Acta Neurol Scand, vol.137, pp.442-451, 2018. ,
Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization, Nature, vol.307, pp.457-460, 1984. ,
Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons, Mol Biol Cell, vol.19, pp.5226-5237, 2008. ,
SV2 Is the Protein Receptor for, Botulinum Neurotoxin A. Science, vol.312, pp.592-596, 2006. ,
Molecular characterization of a novel botulinum neurotoxin type H gene, J Infect Dis, vol.209, pp.192-202, 1097. ,
Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system, J Neurol, vol.260, pp.701-713, 2013. ,
Pharmacology of therapeutic botulinum toxin preparations, Disabil Rehabil, vol.29, pp.1761-1768, 2007. ,
Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin, J Biol Chem, vol.277, pp.34846-34852, 2002. ,
Botulinum toxin inhibits quantal acetylcholine release and energy metabolism in the Torpedo electric organ, J Physiol, vol.385, pp.677-692, 1987. ,
Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain, Brain Res, vol.1702, pp.85-95, 1021. ,
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy, Headache, vol.44, pp.42-75, 2004. ,
Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study, Clin Neurophysiol, vol.124, pp.999-1004, 1013. ,
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models, 2019. ,
The structures of the Hc fragment of Tetanus Toxin with carbohydrate subunit complexes provide insight into ganglioside binding, J. Biol. Chem, vol.275, pp.8889-8894, 2000. ,
Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain, Toxicon, vol.133, pp.116-122, 1013. ,
Infant botulism, Ann Ist Super Sanita, vol.45, pp.134-146, 2009. ,
Synthetic self-assembling clostridial chimera for modulation of sensory functions, Bioconjug Chem, vol.24, pp.1750-1759, 2013. ,
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy, PLoS One, vol.7, 2012. ,
Botulinum A toxin effects on rat jaw muscle spindles, Acta Otolaryngol, vol.113, pp.400-404, 1993. ,
Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B, Proc Natl Acad Sci, vol.116, pp.18098-18108, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02274412
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E and F compared with the long lasting type A, J. Biol. Chem, vol.278, pp.1363-1371, 2003. ,
The crystal structure of Tetanus Toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin, J. Biol. Chem, vol.276, pp.3274-3281, 2001. ,
Recent advances in infant botulism, Pediatr Neurol, vol.32, pp.149-154, 2005. ,
Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F, Biochemistry, vol.48, pp.5631-5641, 2009. ,
Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate, Biochemistry, vol.45, pp.8903-8911, 2006. ,
Translocation and dissemination of botulinum neurotoxin from the intestinal tract, Toxicon, vol.147, pp.13-18, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01826790
The enteric nervous system and gastrointestinal innervation: integrated local and central control, Adv Exp Med Biol, vol.817, pp.39-71, 2014. ,
Hydroxytryptamine (serotonin) in the gastrointestinal tract, Curr Opin Endocrinol Diabetes Obes, vol.20, issue.5, pp.14-21, 2013. ,
Localization of major gangliosides in the PNS: implications for immune neuropathies, Brain, vol.125, pp.2491-2506, 2002. ,
Clostridial neurotoxins: handling and action at the cellular and molecular level, Cur. Top. Microbiol. Immunol, vol.129, pp.93-179, 1986. ,
The unusual history and the urological applications of botulinum neurotoxin, Urol Int, vol.85, pp.125-130, 2010. ,
Calcitonin gene-related peptide-like immunoreactivity, in botulinum toxin-paralysed rat muscles, Neuromuscul Disord, vol.4, pp.489-496, 1994. ,
Interaction of cholera toxin and membrane GM1 ganglioside of small intestine, Proc Natl Acad Sci U S A, vol.72, pp.2520-2524, 1975. ,
How botulinum and tetanus neurotoxins block neurotransmitter release, Biochimie, vol.82, pp.427-446, 2000. ,
Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder, Eur Urol, vol.62, pp.1157-1164, 1123. ,
Effects of botulinum toxin type D on secretion of tumor necrosis factor from human monocytes, Mol Cell Biol, vol.9, pp.2239-2243, 1989. ,
Gangliosides of various rat tissues: distribution of ganglio-N-tetraose-containing gangliosides and tissuecharacteristic composition of gangliosides, J Biochem, vol.95, pp.761-770, 1984. ,
Molecular machines governing exocytosis of synaptic vesicles, Nature, vol.490, pp.201-207, 2012. ,
Botulinum toxin: State of the art, Mov Disord, vol.32, pp.1131-1138, 2017. ,
SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family, Neurosci, vol.94, pp.1279-1290, 1999. ,
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity, Nature, vol.444, pp.1092-1095, 2006. ,
Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin, Biochim Biophys Acta, vol.1156, pp.213-218, 1993. ,
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry, J Biol Chem, vol.287, pp.40806-40816, 2012. ,
Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA, Biochemistry, vol.49, pp.8117-8126, 2010. ,
Vascular permeability in the peripheral autonomic and somatic nervous systems: controversial aspects and comparisons with the blood-brain barrier, Microsc Res Tech, vol.35, pp.122-136, 1996. ,
Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice, Biochim. Biophys. Acta, vol.1441, pp.1-3, 1999. ,
Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction, Neuroscience, vol.159, pp.1422-1429, 1423. ,
Ganglioside biochemistry. ISRN Biochem, p.506160, 2012. ,
Unique ganglioside binding by botulinum neurotoxins C and D-SA, Febs J, vol.278, pp.4486-4496, 2011. ,
Novel gangliosidemediated entry of botulinum neurotoxin serotype D into neurons, J Biol Chem, vol.286, pp.26828-26837, 2011. ,
Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation, J Mol Biol, vol.386, pp.233-245, 2009. ,
Sequence homology and structural analysis of the clostridial neurotoxins, J. Mol. Biol, vol.291, pp.1091-1104, 1999. ,
Crystal structure of botulinum neurotoxin type A and implications for toxicity, Nature Struct. Biol, vol.5, pp.898-902, 1998. ,
Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers, J Pharmacol Exp Ther, vol.334, pp.1080-1086, 2010. ,
Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex, Science, vol.344, pp.1405-1410, 2014. ,
Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons, J Neurosci, vol.31, pp.8998-9009, 2011. ,
Bladder paralysis due to foodborne botulinum toxin type B, Urol J, vol.7, pp.63-65, 2010. ,
Gangliosides in Axon Stability and Regeneration, Prog Mol Biol Transl Sci, vol.156, pp.383-412, 1010. ,
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation, BJU Int, vol.101, pp.366-370, 2008. ,
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves, FEBS Lett, vol.580, pp.2011-2014, 2006. ,
Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E, Biochem J, vol.453, pp.37-47, 2013. ,
Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release, Eur J Biochem, vol.177, pp.683-691, 1988. ,
Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade, Infect. Immun, vol.67, pp.4708-4712, 1999. ,
Nonparalytic botulinum molecules for the control of pain, Pain, vol.157, pp.1045-1055, 2016. ,
Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins, Sci Rep, vol.9, p.1634, 2019. ,
The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes, PLoS One, vol.7, p.47977, 2012. ,
The structure of the tetanus toxin reveals pHmediated domain dynamics, EMBO Rep, vol.18, pp.1306-1317, 2017. ,
Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons, Pain, vol.155, pp.1516-1526, 1512. ,
The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption, Cell Microbiol, vol.10, pp.355-364, 2008. ,
Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity, Nat Commun, vol.6, p.6255, 2015. ,
The absorption of Clostridium botulinum type Atoxin from the alimentary canal, Br. J. Exp. Path, vol.39, pp.307-316, 1958. ,
Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gammaaminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action, J Biol Chem, vol.267, pp.21338-21343, 1992. ,
Selective Cleavage of SNAREs in Sensory Neurons Unveils Protein Complexes Mediating Peptide Exocytosis Triggered by Different Stimuli, Mol Neurobiol, vol.8, 2014. ,
Botulism type B presenting as pure autonomic dysfunction, Clin Auton Res, vol.13, pp.337-338, 2003. ,
Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin, Pflugers Arch, vol.431, pp.297-298, 1996. ,
Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions, J Physiol (Paris), vol.84, pp.152-166, 1990. ,
Botulinum Neurotoxin: A Marvel of Protein Design, Annu Rev Biochem, vol.79, pp.591-617, 2010. ,
How do tetanus and botulinum toxins to neuronal membranes?, TIBS, vol.11, pp.314-317, 1986. ,
Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons, Am J Physiol Heart Circ Physiol, vol.283, pp.2627-2635, 2002. ,
Clostridium neurotoxins influence serotonin uptake and release differently in rat brain synaptosomes, J Neurochem, vol.72, 1991. ,
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders, Toxicon, vol.67, pp.141-52, 1023. ,
Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal, J Cell Biol, vol.147, pp.1249-1260, 1999. ,
Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes, J. Biol. Chem, vol.269, pp.10498-10503, 1994. ,
The high-affinity of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides G T1B /G D1a, FEBS Lett, vol.378, pp.253-257, 1996. ,
Binding of Clostridium botulinum neurotoxin to gangliosides, J Biochem, vol.100, pp.27-33, 1986. ,
Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses, J Neurosci, vol.26, pp.13493-13504, 2006. ,
Botulinum Toxin for the Treatment of Neuropathic Pain, Toxins (Basel), vol.9, issue.9, p.9090260, 2017. ,
, Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature. Toxins (Basel) 9, p.38, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01821691
Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum, Strain. mSphere, vol.1, issue.1, 2016. ,
Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations, FEBS Lett, p.13508, 2019. ,
Botulinum neurotoxin D-C uses synaptotagmin I/II as receptors and human synaptotagmin II is not an effective receptor for type B, D-C, and G toxins, J Cell Sci, vol.125, pp.3233-3242, 2012. ,
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors, PLoS Pathog, vol.7, 2011. ,
Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells, Nature, vol.324, pp.76-78, 1986. ,
Challenges in searching for therapeutics against Botulinum Neurotoxins, Expert Opin Drug Discov, vol.12, pp.497-510, 2017. ,
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology, Pharmacol Rev, vol.69, pp.200-235, 2017. ,
Absorption and transport of botulinum neurotoxins, Molecular Aspects of Botulinum Neurotoxin, pp.35-68, 2014. ,
Structural and genomic features of clostridial neurotoxins, The Comprehensive Sourcebook of Bacterial Protein Toxins, vol.2, pp.174-201, 1999. ,
Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells, Toxins (Basel), vol.2, pp.683-737, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01788650
Quantal neurotransmitter release and the clostridial neurotoxins' targets, Curr Top Microbiol Immunol, vol.195, pp.243-255, 1995. ,
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?, Toxins (Basel), vol.11, issue.1, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02328868
How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action, Botulinum J, vol.1, pp.14-87, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00303601
Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain, Proc Natl Acad Sci U S A, vol.85, pp.4090-4094, 1988. ,
Therapeutic use of botulinum toxin in migraine: mechanisms of action, Br J Pharmacol, vol.171, pp.4177-4192, 2014. ,
Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder, J Urol, vol.175, pp.1138-1142, 2006. ,
Mutational analysis of VAMP domains implicated in Ca2+-induced insulin exocytosis, Embo J, vol.15, pp.6951-6959, 1996. ,
Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons, PLoS Pathog, vol.8, 2012. ,
Botulinum neurotoxin a impairs neurotransmission following retrograde transynaptic transport, Traffic, vol.13, pp.1083-1089, 2012. ,
Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study, Heart Rhythm, vol.16, pp.172-177, 1017. ,
Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection, Muscle Nerve, vol.19, pp.488-496, 1996. ,
On muscle spindles, dystonia and botulinum toxin, Eur J Neurol, vol.17, pp.71-80, 2010. ,
Infant botulism: review and clinical update, Pediatr Neurol, vol.52, pp.487-492, 2015. ,
The binding of botulinum neurotoxins to different peripheral neurons, Toxicon, vol.147, pp.27-31, 1016. ,
Current gaps in basic science knowledge of botulinum neurotoxin biological actions, Toxicon, vol.107, pp.59-63, 2015. ,
, Tetanus neurotoxin. Toxicon, vol.66, pp.59-63, 1016.
Two Feet on the Membrane: Uptake of Clostridial Neurotoxins, Curr Top Microbiol Immunol, vol.406, pp.1-37, 2017. ,
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept, Proc Natl Acad Sci U S A, vol.104, pp.359-364, 2007. ,
Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor, J Neurochem, vol.110, pp.1942-1954, 2009. ,
Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G, J. Biol. Chem, vol.279, pp.30865-30870, 2004. ,
The H cc -domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction, Mol. Microbiol, vol.51, pp.631-643, 2004. ,
Calcitonin gene-related peptide: physiology and pathophysiology, Physiol Rev, vol.94, pp.1099-1142, 2014. ,
Botulinum toxin treatment of pain syndromes -an evidence based review, Toxicon, vol.147, pp.120-128, 1011. ,
Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions, J Neurosci, vol.15, pp.520-528, 1995. ,
Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes, Eur J Biochem, vol.165, pp.675-681, 1987. ,
Transient paralysis of the bladder due to wound botulism, Eur Urol, vol.39, pp.610-612, 2001. ,
Gangliosides of the Vertebrate Nervous System, J Mol Biol, vol.428, pp.3325-3336, 2016. ,
The Biology of Gangliosides, Adv Carbohydr Chem Biochem, vol.76, pp.113-148, 1023. ,
Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration, Physiol Rev, vol.94, pp.461-518, 2014. ,
Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment, BJU Int, vol.100, pp.1075-1080, 2007. ,
Botulinum toxin injection of eye muscles to correct strabismus, Trans Am Ophthalmol Soc, vol.79, pp.734-770, 1981. ,
Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A, Neurobiol Dis, vol.48, pp.367-378, 1020. ,
The life history of a botulinum toxin molecule, Toxicon, vol.68, pp.40-59, 2013. ,
The origin, structure, and pharmacological activity of botulinum toxin, Pharmacol Rev, vol.33, pp.155-188, 1981. ,
Ganglioside inactivation of botulinum toxin, J Neurochem, vol.18, pp.1341-1343, 1971. ,
Human response to botulinum toxin injection: type B compared with type A, Neurology, vol.49, pp.189-194, 1997. ,
Bacterial protein toxins as biological weapons, The Comprehensive Sourcebook of Bacterial Protein Toxins, pp.1019-1030, 2006. ,
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization, Infect Immun, vol.73, pp.5450-5457, 2005. ,
Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery, Am J Physiol Heart Circ Physiol, vol.290, pp.1818-1825, 2006. ,
, Botulism. Clin Infect Dis, vol.41, pp.1167-1173, 2005.
Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction, PLoS Pathog, vol.4, 2008. ,
A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency, PLoS Pathog, vol.14, 2018. ,
The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites, Mol Microbiol, vol.81, pp.143-156, 2011. ,
Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner, Biochem J, vol.431, pp.207-216, 2010. ,
Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A, FEBS Lett, vol.588, pp.1087-1093, 2014. ,
Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity, FEBS Lett, vol.586, pp.310-313, 2012. ,
Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin, J Cell Biol, vol.189, pp.691-700, 2010. ,
, The travel diaries of tetanus and botulinum neurotoxins, vol.147, pp.58-67, 2018.
Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord, Biochim Biophys Acta, vol.1214, pp.90034-90035, 1094. ,
Molecular structures and functional relationships in clostridial neurotoxins, Febs J, vol.278, pp.4467-4485, 2011. ,
Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B, Nature Struct. Biol, vol.7, pp.693-699, 2000. ,
Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin, J Am Acad Dermatol, vol.51, pp.739-745, 2004. ,
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors, Nat Commun, vol.8, p.53, 2017. ,
Botulinum neurotoxins: Mechanism of action, Toxicon, vol.67, pp.87-93, 2012. ,
Binding of Clostridium botulinum types C and D neurotoxins to ganglioside and phospholipid, J. Biol. Chem, vol.280, pp.35164-35171, 2005. ,
The structure of the receptor binding fragment H c of tetanus neurotoxin, Nature Struct. Biol, vol.4, pp.788-792, 1997. ,
Acetylcholine and ATP are coreleased from the electromotor nerve terminals of Narcine brasiliensis by an exocytotic mechanism, Proc Natl Acad Sci U S A, vol.87, pp.553-557, 1990. ,
Differential distribution of major brain gangliosides in the adult mouse central nervous system, PLoS One, vol.8, p.75720, 2013. ,
The fixation of tetanus toxin by ganglioside, J. Gen. Microbiol, vol.24, pp.107-119, 1961. ,
Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes, J Neurochem, vol.73, pp.372-379, 1999. ,
Traffic of botulinum toxins A and E in excitatory and inhibitory neurons, Traffic, vol.8, pp.142-153, 2007. ,
SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization, Neuron, vol.41, pp.599-610, 2004. ,
Central Effects of Botulinum Neurotoxin-Evidence from Human Studies, Toxins (Basel), vol.11, issue.1, 2019. ,
Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than, Botulinum Neurotoxin B Synaptotagmin. Toxins (Basel), vol.8, issue.5, 2016. ,
Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins, Toxicon, vol.38, pp.245-258, 2000. ,
Tetanus and Botulinum Neurotoxins, Selective Neurotoxicity, pp.357-417, 1992. ,
Closed Genome Sequence of Chryseobacterium piperi Strain CTM(T)/ATCC BAA-1782, a Gram-Negative Bacterium with Clostridial Neurotoxin-Like Coding Sequences, Genome Announc, vol.5, pp.1296-01217, 2017. ,
Botulinum Neurotoxin G Binds Synaptotagmin-II in a Mode Similar to That of Serotype B: Tyrosine 1186 and Lysine 1191 Cause Its Lower Affinity, Biochemistry, p.17, 2013. ,
Inhibition by botulinum toxin of depolarizationevoked release of (14C)acetylcholine from synaptosomes in vitro, Biochem J, vol.156, pp.701-712, 1976. ,
Botulinum toxin decreases hyperalgesia and inhibits P2X3 receptor over-expression in sensory neurons induced by ventral root transection in rats, Pain Med, vol.12, pp.1385-1394, 1182. ,
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A, Nat Struct Mol Biol, vol.23, pp.656-662, 2016. ,
Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons, J Pain Res, vol.4, pp.347-55, 2011. ,
Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I, J. Biol. Chem, vol.277, pp.32815-32819, 2002. ,
Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC, Nat Commun, vol.8, p.1637, 2017. ,
Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium, Cell Host Microbe, vol.23, pp.169-176, 2018. ,
Identification and characterization of a novel botulinum neurotoxin, Nat Commun, vol.8, 2017. ,
Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D, Biochem Biophys Res Commun, vol.401, pp.498-503, 1019. ,
The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain, Sci Rep, vol.6, p.30257, 2016. ,